Ocata Therapeutics Inc fka OCAT

[rocky822]

Advanced Cell Technology CEO Interviewed on CNBC’s ''Power Lunch''
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.’s (OTCBB: ACTC) William M. Caldwell, IV, Chief Executive Officer, was interviewed on CNBC Television’s “Power Lunch” yesterday to comment on a recent discovery by scientists at Wake Forest University describing a method of deriving stem cells from human amniotic fluid and a bill Congress is expected to take up today to widen the scope of funding for embryonic stem cell research.

Mr. Caldwell commented, “The key for any successful company is focus and we are very driven towards taking therapies, specifically for retinal, blood and cardiac disease into the clinic and ultimately patients. We are excited for Wake Forest and Doctor Atala…[t]hose breakthroughs are exciting and we are going to see more breakthroughs. It’s important to remember that the key master cell is the embryonic stem cell and that’s the one we are focused on.”

Mr. Caldwell continued, “The industry has been starved for many years for lack of capital and we began seeing activity back in 2004 with the voters of California. Now with Congress revisiting the veto that occurred last summer we are going to see a lot more activity in the sector, and we are very excited about it.”

The interview can be viewed at: http://www.cnbc.com/id/15840232?video=162856951&play=1

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.